
CON
USDConcentra Group Holdings Parent Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$21.180
Kõrge
$21.310
Madal
$20.950
Maht
0.05M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
2.7B
Tööstusharu
Medical Care Facilities
Riik
United States
Kauplemisstatistika
Keskmine maht
0.80M
Börs
NYQ
Valuuta
USD
52 nädala vahemik
Tehisintellekti analüüsiaruanne
Viimati uuendatud: 24. apr 2025CON: Concentra Group Holdings Parent Inc. Common Stock - Analyzing Recent Moves & What Might Come Next
Stock Symbol: CON Generate Date: 2025-04-24 01:26:16
Let's break down what's been happening with Concentra Group Holdings stock lately and what the data might suggest.
Recent News Buzz: What's the Vibe?
Looking at the latest headlines, the feeling around Concentra seems pretty positive overall.
First off, we know they're planning to announce their first quarter results on May 7th. That's just a date to watch for now, but earnings reports are always a big deal for a stock.
More recently, back in March, a big bank, JP Morgan, kept their "Overweight" rating on Concentra. That's analyst talk for "we think this stock is likely to do better than the average stock." Not only that, they actually raised their price target slightly, from $29 to $30. That's a clear vote of confidence from a professional observer.
Also in March, the company announced they opened a new medical center in Waukegan, Illinois. Concentra is a leader in occupational medicine, so opening new locations shows they're expanding their business. That's generally seen as a good sign for future growth.
So, putting the news together, you've got a major analyst feeling good about the stock and the company actively growing its footprint. That paints a picture of positive momentum.
Price Action: What's the Stock Been Doing?
Now, let's look at the stock price itself over the last month or two.
Back in late January and early February, the stock was trading higher, up around the $23-$24 mark. But then it started a pretty steady slide through February and into March, hitting lows around $20.50 to $21.00 by mid-March.
Since then, it's been a bit of a choppy ride. It bounced up a bit in late March and early April, even touching over $22.50 briefly. But then it dropped back down again pretty quickly. For the last couple of weeks, it's mostly been trading in a range roughly between $19.50 and $21.00.
The last recorded price was $20.89. So, it's currently sitting in the upper half of that recent choppy range, but still well below where it was earlier in the year.
What about the AI's take? The prediction model sees the stock price staying flat today (0.0% change), then a small bump tomorrow (+0.56%), followed by a more significant jump the day after (+3.63%). If that prediction plays out, the stock could be heading towards the $21.60 area in the next couple of days.
Putting It Together: Potential Outlook & Strategy Ideas
Based on the news, the recent price action, and the AI's short-term forecast, what does it all suggest?
The positive news (analyst upgrade, expansion) and the AI predicting an upward move from here might lean things slightly towards a positive outlook in the very near term. The stock has been volatile, but the AI thinks it's ready for a bounce.
Given the AI's prediction of a rise starting now, considering the current price area around $20.89 could be one approach if you're looking to potentially ride that predicted wave. The AI's forecast suggests the upward movement could begin right away.
If you were considering getting in, managing your risk is always key. A potential level to watch for cutting losses (a stop-loss) could be somewhere below the recent lows we saw earlier this month, maybe around $19.30 or $19.00. That would be a signal that the recent choppy range is breaking down.
For taking profits, the AI's prediction points towards the $21.60 area in the next couple of days. The JP Morgan analyst has a much higher long-term target of $30, which shows the potential room to grow if the company performs well over time.
Company Context
Just remember, Concentra is in the healthcare sector, specifically focusing on occupational health services. Things like workers' compensation, employer health services, and physical exams are their bread and butter. So, news about opening new clinics, like the one in Illinois, directly relates to their core business and ability to grow revenue.
Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are risky, and prices can go down as well as up. You should always do your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.
Seotud uudised
Concentra® to Announce First Quarter 2025 Results on Wednesday, May 7, 2025
Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) will release the financial results for its first quarter ended March 31, 2025, on Wednesday, May 7, 2025, after the market closes. Concentra will
JP Morgan Maintains Overweight on Concentra Group Holdings, Raises Price Target to $30
JP Morgan analyst Lisa Gill maintains Concentra Group Holdings with a Overweight and raises the price target from $29 to $30.
Concentra Expands to Waukegan, Illinois
Concentra®, the nation's leader in occupational medicine, today announced the opening of a new medical center in Waukegan, Illinois. The medical center, Concentra Waukegan, is conveniently located at 3043A
Tehisintellekti ennustusBeta
Tehisintellekti soovitus
Uuendatud kell: 28. apr 2025, 06:42
70.2% Kindlus
Risk ja kauplemine
Sisenemispunkt
$21.10
Võta kasum
$21.66
Peata kahjum
$19.12
Põhitegurid
Seotud aktsiad

VALN
Valneva SE American Depositary Shares

PSBD
Palmer Square Capital BDC Inc.

SATX
SatixFy Communications Ltd. Ordinary Share

RGNX
REGENXBIO Inc.

ZKH
ZKH Group Limited American Depositary Shares each representing thirty-five (35) Ordinary Shares
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.